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Asthma is a heterogeneous chronic inflammatory condition with 
variable airflow limitation and characterised by airway reversibility.[1] 
Globally, asthma is among the top five most common respiratory 
non-communicable diseases, with an estimate of >300 million 
sufferers.[2] The 2015 Global Burden of Disease Study found that 
worldwide 4 million deaths are due to chronic respiratory disease, 
with 80 - 90% occurring in low- and middle-income countries, 
including South Africa (SA).[3,4] In a modelling study, asthma 
prevalence was found to be increasing in adults and children in 
Africa. Asthma rates almost tripled over 20 years – from 40 million 
in 1990 to 119 million in 2010.[5]
In the International Study of Asthma and Allergies in Childhood 
(ISAAC), SA children were found to have the highest prevalence of 
asthma symptoms: >20% in 13 - 14-year-olds and >50% with severe 
asthma symptoms, reflecting a high morbidity due to asthma.[6,7] An 
increasing prevalence of asthma has also been linked to increased rates 
of urbanisation. The following are risk factors for the development of 
asthma and more severe asthma symptoms: urbanisation, which is 
associated with increased exposure to air pollution due to traffic, 
poor ventilation of houses in peri-urban areas, high levels of violence, 
psychosocial stressors and little physical activity. 
Despite SA having an excellent package of medications for asthma 
care in the Standard Treatment Guidelines and Essential Medicines  List 
for South Africa,[8] the number of asthma deaths remains high, with 
SA being among the top 10 countries in the world in terms of such 
deaths.[9] The key to improving asthma-related outcomes is linked 
to three main pillars: access to a diagnosis being made, appropriate 
access to medication, and education to improve adherence and 
achieve asthma control. In this issue of CME, the South African 
Childhood Asthma Working Group (SACAWG)[10,11] reviews the 
epidemiology, diagnosis and control of asthma in children. 
Diagnosis of paediatric asthma is particularly challenging, 
especially in preschool children ˂5 years of age. Although this age 
group has a low mortality risk, there is significant morbidity owing 
to over-utilisation of healthcare resources, e.g. multiple visits to 
healthcare providers, use of unnecessary and sometimes harmful 
medications and the need for repeated admissions. Primary-level 
healthcare providers do not feel confident to make the diagnosis 
of asthma in young children. Consequently, recurrent wheezing in 
a preschool child is not documented or is attributed to conditions 
other than asthma. Furthermore, the current traditional diagnostic 
tools for asthma in children >6 years old to demonstrate airways 
reversibility are difficult to use in preschool children. Noting these 
diagnostic challenges, a key change to the recommendations in 
confirming the presence of asthma in this age group is the concept of 
a 6 - 8-week trial of medication, followed by a period of cessation of 
treatment to confirm the diagnosis of asthma. Should the symptoms 
recur with discontinuation of therapy, a diagnosis of asthma can then 
confidently be made. 
Achieving asthma control is one of the goals of asthma treatment. 
Poor asthma control is linked to a diminished quality of life and 
escalation of direct and indirect costs with regard to the condition. 
While an assessment of asthma control should be done during each 
follow-up visit, the new recommendations have been adapted to 
include the assessment of future risk for poor asthma outcomes, in 
line with the Global Initiative for Asthma recommendations.[1]
A diagnosis of asthma and access to treatment are achievable 
goals in SA, even in young children, as long as healthcare providers 
perform a simple risk assessment and initiate a therapeutic trial of 
medications, thereby reversing the current status quo of poor access 
to diagnosis and therefore appropriate 
accessible treatment. 
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